These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8133095)

  • 1. Determination of hepatitis E virus seroprevalence by using recombinant fusion proteins and synthetic peptides.
    Paul DA; Knigge MF; Ritter A; Gutierrez R; Pilot-Matias T; Chau KH; Dawson GJ
    J Infect Dis; 1994 Apr; 169(4):801-6. PubMed ID: 8133095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enzyme immunoassay for the detection of antibody to hepatitis E virus based on synthetic peptides.
    Favorov MO; Khudyakov YE; Fields HA; Khudyakova NS; Padhye N; Alter MJ; Mast E; Polish L; Yashina TL; Yarasheva DM
    J Virol Methods; 1994 Feb; 46(2):237-50. PubMed ID: 8188817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of antibodies to hepatitis E virus in immigrants: a seroepidemiological survey in the district of Foggia (Apulia-southern Italy).
    Scotto G; Martinelli D; Giammario A; Prato R; Fazio V
    J Med Virol; 2013 Feb; 85(2):261-5. PubMed ID: 23192767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of sporadic cases of hepatitis E virus (HEV) infection in China using immunoassays based on recombinant open reading frame 2 and 3 polypeptides from HEV genotype 4.
    Wang Y; Zhang H; Li Z; Gu W; Lan H; Hao W; Ling R; Li H; Harrison TJ
    J Clin Microbiol; 2001 Dec; 39(12):4370-9. PubMed ID: 11724847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of human (genotype 1) and swine (genotype 4)-ORF2-based ELISAs for anti-HEV IgM and IgG detection in an endemic country and search for type 4 human HEV infections.
    Arankalle VA; Lole KS; Deshmukh TM; Chobe LP; Gandhe SS
    J Viral Hepat; 2007 Jun; 14(6):435-45. PubMed ID: 17501765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New immunoassays for total, IgA and IgM antibodies against hepatitis E virus: Prevalence in Italian blood donors and patients with chronic liver or kidney diseases.
    Ricco G; Bonino F; Lanza M; Scatena F; Alfieri CM; Messa P; Marchisio E; Mascolo G; Romanò L; Galli C; Li TC; Wakita T; Miyamura T; Brunetto MR
    Dig Liver Dis; 2016 May; 48(5):536-541. PubMed ID: 26936342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis E virus in Cuba.
    Lemos G; Jameel S; Panda S; Rivera L; Rodríguez L; Gavilondo JV
    J Clin Virol; 2000 Feb; 16(1):71-5. PubMed ID: 10680744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgM and IgG antibodies to hepatitis E virus (HEV) detected by an enzyme immunoassay based on an HEV-specific artificial recombinant mosaic protein.
    Favorov MO; Khudyakov YE; Mast EE; Yashina TL; Shapiro CN; Khudyakova NS; Jue DL; Onischenko GG; Margolis HS; Fields HA
    J Med Virol; 1996 Sep; 50(1):50-8. PubMed ID: 8890041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of immunoglobulin M antibodies to hepatitis E virus by class capture enzyme immunoassay.
    Yu C; Engle RE; Bryan JP; Emerson SU; Purcell RH
    Clin Diagn Lab Immunol; 2003 Jul; 10(4):579-86. PubMed ID: 12853389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Varying abilities of recombinant polypeptides from different regions of hepatitis E virus ORF2 and ORF3 to detect anti-HEV immunoglobulin M.
    Ma H; Song X; Li Z; Harrison TJ; Zhang H; Huang W; Hao W; Kong W; Wang Y
    J Med Virol; 2009 Jun; 81(6):1052-61. PubMed ID: 19382255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis E virus in donor plasma collected in Japan.
    Minagi T; Okamoto H; Ikegawa M; Ideno S; Takahashi K; Sakai K; Hagiwara K; Yunoki M; Wakisaka A
    Vox Sang; 2016 Oct; 111(3):242-246. PubMed ID: 27280485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new enzyme immunoassay for the detection of antibody to hepatitis E virus.
    Obriadina A; Meng JH; Ulanova T; Trinta K; Burkov A; Fields HA; Khudyakov YE
    J Gastroenterol Hepatol; 2002 Dec; 17 Suppl 3():S360-4. PubMed ID: 12472964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of assays for antibody to hepatitis E virus by a serum panel. Hepatitis E Virus Antibody Serum Panel Evaluation Group.
    Mast EE; Alter MJ; Holland PV; Purcell RH
    Hepatology; 1998 Mar; 27(3):857-61. PubMed ID: 9500718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of hepatitis E virus (HEV) antibodies in Serbian blood donors.
    Petrović T; Lupulović D; Jiménez de Oya N; Vojvodić S; Blázquez AB; Escribano-Romero E; Martín-Acebes MA; Potkonjak A; Milošević V; Lazić S; Saiz JC
    J Infect Dev Ctries; 2014 Oct; 8(10):1322-7. PubMed ID: 25313610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of and risk factors for antibody to hepatitis E virus seroreactivity among blood donors in Northern California.
    Mast EE; Kuramoto IK; Favorov MO; Schoening VR; Burkholder BT; Shapiro CN; Holland PV
    J Infect Dis; 1997 Jul; 176(1):34-40. PubMed ID: 9207347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of antibodies to hepatitis E virus among Japanese blood donors: identification of three blood donors infected with a genotype 3 hepatitis E virus.
    Fukuda S; Sunaga J; Saito N; Fujimura K; Itoh Y; Sasaki M; Tsuda F; Takahashi M; Nishizawa T; Okamoto H
    J Med Virol; 2004 Aug; 73(4):554-61. PubMed ID: 15221899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of Hepatitis E virus-specific antibodies in sera of German domestic pigs estimated by using different assays.
    Baechlein C; Schielke A; Johne R; Ulrich RG; Baumgaertner W; Grummer B
    Vet Microbiol; 2010 Jul; 144(1-2):187-91. PubMed ID: 20045268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Proline-Rich Domain in the Genotype 4 Hepatitis E Virus ORF3 C-Terminus Is Crucial for Downstream V105DLP108 Immunoactivity.
    Wang H; Ji F; Liang H; Gu H; Ning Z; Liu R; Zhang G
    PLoS One; 2015; 10(7):e0133282. PubMed ID: 26177202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discrepancy between anti-hepatitis E virus immunoglobulin G prevalence assessed by two assays in kidney and liver transplant recipients.
    Rossi-Tamisier M; Moal V; Gerolami R; Colson P
    J Clin Virol; 2013 Jan; 56(1):62-4. PubMed ID: 23089569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short report: further evidence for hepatitis E in the Brazilian Amazon.
    Souto FJ; Fontes CJ; Parana R; Lyra LG
    Am J Trop Med Hyg; 1997 Aug; 57(2):149-50. PubMed ID: 9288806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.